Year: 2019
Type: review
Source: Cancer Treatment Reviews
Authors: Rosa Nadal, Joaquim Bellmunt
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Keywords: metastatic bladder cancer, urothelial carcinoma, immune checkpoint inhibitors, PD-1/PD-L1, atezolizumab, pembrolizumab, erdafitinib, FGFR inhibitors, enfortumab vedotin, antibody-drug conjugates, platinum-based chemotherapy, treatment resistance, treatment response biomarkers, quality of life
Open Access status: green
OpenAlex ID: W2936221437
